{
  "ticker": "OPL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972759",
  "id": "02972759",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250725",
  "time": "1327",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250725/pdf/06m4kfnzx46087.pdf",
  "summary": "### **Material Information Summary**  \n\n- **All resolutions at the General Meeting (25 July 2025) passed**, including:  \n  - Ratification of prior share issuances (25.1M, 16.9M, and 500K shares).  \n  - Approval for **placement options** and **broker options**.  \n  - **Change of company name** (98.7% approval).  \n  - **Conversion of loans to equity** for Irwin Biotech Nominees and Maryton Australia.  \n  - **Securities issuance to Director Antanas Guoga**.  \n  - **Incentive performance rights granted to Director Saurabh Jain** (99.92% approval).  \n\n*No capital raising or trading halt implications identified.*",
  "usage": {
    "prompt_tokens": 1694,
    "completion_tokens": 156,
    "total_tokens": 1850,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-25T04:16:34.098158"
}